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 The  ‘ hyperfiltration theory ’ was pro-
posed in the last century to explain the 
progression of chronic kidney disease to 
end-stage renal disease, independently 
of the persistence or lack of persistence 
of the original cause. Th e main postulate 
of the hyperfi ltration theory was that 
when the number of functioning neph-
rons is reduced below a critical number, 
they start to suff er functional and struc-
tural adaptations, initially maintaining 
renal functions but eventually causing 
progressive glomerulosclerosis, pro-
teinuria, and fi nally renal failure in the 
long term. 1,2 Th e basis of such damage 
was seen as centering around hemody-
namic adaptations in the surviving 
glomeruli, including vasodilation of 
aff erent glomerular arterioles, increased 
fi ltration fraction, and increased glomer-
ular transcapillary hydraulic pressure. 
 Th e experimental model in which most 
of the investigations about glomerular 
hyperfi ltration were developed was the 
renal ablation model (5 / 6 nephrectomy) 
performed in rats. It was an extremely 
important concept that led to the demon-
stration that the measures that decrease 
glomerular filtration fraction through 
preglomerular vasoconstriction (low-pro-
tein diet) or postglomerular vasodilation 
(angiotensin-converting enzyme inhibi-
tors) signifi cantly improved glomerular 
lesions associated with a reduction in 
nephron number. 1,2 
 From a clinical point of view, it was 
expected that patients with a severe reduc-
tion in renal mass or in the number of 
functioning nephrons because of surgical 
causes, congenital abnormalities, or previ-
ous severe renal diseases would prove to 
be the best clinical correlates of the hyper-
fi ltration hypothesis. However, the appli-
cation of these theoretical principles to 
clinical practice was (as usual) not easily 
extrapolated: a significant number of 
patients with extreme reductions in renal 
mass (for example, patients with bilateral 
renal carcinomas submitted to   >  80 % 
renal parenchyma resection) did not 
develop proteinuria or renal insuffi  ciency 
aft er many years of follow-up. 3 Another 
theory that, at least partially, could explain 
these discrepancies was the Barker 
hypothesis: undernutrition and other 
intrauterine conditions can result in low 
birth weight, and several studies have 
demonstrated that people who had low 
birth weight have fewer nephrons. 4 It has 
been shown that nephron number at birth 
can oscillate from 250,000 per kidney to 
as high as 1,800,000 in otherwise healthy 
newborns. Intuitively, individuals 
endowed at birth with a greater number 
of nephrons could be more resistant to the 
harmful consequences of renal mass 
reduction (or obesity) than those with a 
reduced number. 
 Th e hyperfi ltration theory was again 
invoked in the setting of the worldwide 
epidemic of obesity and type 2 diabetes. 
As has been repeatedly demonstrated, 
most obese and diabetic subjects tend to 
exhibit the same pattern of glomerular 
hemodynamics as patients and animals 
with reduced renal mass (preglomerular 
vasodilation, increased glomerular fi ltra-
tion rate and fi ltration fraction). However, 
the pathophysiological mechanisms of 
such hyperfi ltration in the presence of 
normal renal mass are not completely 
understood. 5 Glomerular fi ltration rate 
(GFR) in obese people is observed to be 
much higher, and proteinuria and second-
ary glomerulosclerosis are now recog-
nized as specifi c complications of severe 
obesity. Although uncontrolled diabetes 
induces glomerular hyperfiltration by 
itself, obesity, commonly preceding the 
appearance of type 2 diabetes, is very 
likely to play an important role in both the 
pathogenesis of glucose intolerance and 
the appearance of glomerular complica-
tions. We have studied several type 2 dia-
betic patients with overt proteinuria and 
morbid obesity who were submitted to 
bariatric surgery (unpublished data). Aft er 
this procedure, and coinciding with 
signifi cant weight loss, both glucose into-
lerance and proteinuria practically dis-
appeared, underscoring the key role of 
obesity in these disorders. 
 Surprisingly, in spite of the alarming 
worldwide spread of obesity and of epide-
miologic studies linking obesity with the 
development of renal insuffi  ciency, few 
clinical studies have investigated the infl u-
ence of dietary modifi cations on markers 
of kidney function and disease in obese 
subjects. A number of studies, most of 
them performed in the last century, dem-
onstrated that a protein load, either oral 
or intravenous, markedly increases GFR 
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and fi ltration fraction. 6 Hence, continu-
ous intake of a high-protein diet could 
exacerbate glomerular hyperfi ltration and 
be potentially harmful in obesity-related 
nephropathy. However, these investiga-
tions were not performed in obese sub-
jects as a separate group. It would be of 
considerable clinical interest to fi nd out 
whether the characteristic hyperfi ltration 
of obese people could be induced, at least 
partially, by the high amounts of protein 
that most of them consume. 
 To answer this question, Friedman and 
colleagues 7 (this issue) analyzed the 
eff ects of high-protein (140  g / d) and low-
protein (50  g / d) diets in 17 obese subjects. 
Participants were randomly allocated in 
a double-blind crossover design to receive 
a 1-week high-protein diet, followed by a 
1-week washout period, followed by a 
1-week low-protein diet, or the reverse. 
In order to rule out spurious infl uences of 
other dietary components and avoid 
weight changes, all meals contained the 
same amount of sodium (4  g / d) and were 
isocaloric (30 – 35  kcal / kg / d). Th e authors 
found that high-protein diet was associ-
ated with a modest but significant 
increase in GFR (114 ± 25 versus 
109 ± 26  ml / min, a diff erence of 5  ml / min). 
Total urinary protein tended to increase 
(188 ± 73 versus 173 ± 84  mg / d), whereas 
albuminuria tended to decrease (9 mg / d 
versus 11 mg / d), though neither of them 
achieved statistical signifi cance. Th ere 
were no changes in serum creatinine, 
cystatin C, blood pressure, fasting glu-
cose, or homeostasis model assessment 
score. Th e main conclusion of the authors 
is that dietary protein is unlikely to fully 
explain obesity-related elevations in GFR 
and proteinuria. 
 Some of the limitations of this study, par-
ticularly its size (17 subjects), were compen-
sated by its rigorous design and the careful 
control of the dieticians who prepared 
meals and assessed dietary compliance 
throughout the study. Corroborating par-
ticipants ’ compliance, serum blood urea 
nitrogen, 24-h urinary urea excretion, and 
estimated protein consumption were twice 
as much on the high-protein diet, whereas 
body weights were unchanged. 
 Another limitation of the study was the 
absence of a lean-matched control group that 
would further help to quantify the separate 
infl uences of dietary proteins and obesity. 
On the other hand, the study was performed 
in obese subjects without any evidence of 
renal disease (normal renal function, no sig-
nifi cant proteinuria). Whether or not the 
results might be applicable to patients with 
clinically evident obesity-related nephropa-
thy, and whether a sustained consumption of 
high-protein diets could have consequences 
diff erent from those observed aft er only one 
week on such a diet, are issues that remain to 
be elucidated. 
 In addition to analyzing the renal eff ects 
of dietary protein, as the study by Friedman 
 et al. 7 does, more investigations are needed 
to clarify the renal consequences of hypoc-
aloric diets in obese people. Some clinical 
studies and case reports have shown how 
dramatically an important weight loss by 
caloric restriction can reduce proteinuria —
 even by more than 80 % of the baseline val-
ues. Nevertheless, some preliminary clinical 
observations suggest that such antipro-
teinuric eff ect is directly induced by caloric 
restriction by itself, far before the achieve-
ment of a signifi cant weight loss. Our group 
published a prospective randomized study 
in overweight or obese patients (body mass 
index   >  27  kg / m 2 ) with proteinuria greater 
than 1  g per 24  h. 8 They were randomly 
assigned either to follow a low-calorie diet 
or to maintain their usual diet for 5 months. 
Patients assigned to the low-calorie group 
were prescribed a diet with an energy reduc-
tion of 500  kcal with respect to their usual 
diet and a protein content of 1 – 1.2  g / kg / d. 
Aft er 5 months, they had lost 4.1 ± 3 % of 
their baseline weight, and mean body mass 
index decreased from 33 ± 3.5 to 
31.6 ± 3.2  kg / m 2 . In spite of this rather mod-
est weight loss and even though protein 
intake was unchanged, mean proteinuria 
showed a signifi cant decrease from 2.8 ± 1.4 
to 1.9 ± 1.4  g per 24  h, equivalent to a 
31.2 ± 37 % reduction in baseline values. But, 
very interestingly, this reduction in pro-
teinuria was almost completely achieved 
(26.4 ± 30 % of baseline values) aft er only 
1 month of hypocaloric diet, when patients 
had lost only 2.8 ± 2.1 % of the baseline 
weight 8 ( Figure 1 ). 
 The pathophysiological mechanisms 
responsible for such early infl uences of calo-
rie restriction on obesity-related nephropa-
thy deserve further investigations. For 
example, recent studies have shown that 
lower adiponectin and higher fetuin-A 
serum levels associate with obesity, metabolic 
syndrome, and albuminuria. 9 Several inves-
tigations suggest that both proteins (working 
in opposite directions) could orchestrate the 
cross-talk among fat, kidney, and liver. Inhi-
bition of the activity of the energy sensor 
5  -AMP-activated protein kinase (AMPK), 
mainly through the lack of adiponectin stim-
ulation, would play an important role in the 
harmful consequences of obesity for renal 
and liver parenchyma. Interestingly, caloric 
restriction induces a decline in serum fetuin-
A, an increase in adiponectin levels, and a 
stimulation of AMPK. 9 Th e eff ects of dietary 
modifi cations on the secretion of oxidized 
polyunsaturated fatty acids and on the 
enhanced aldosterone signaling that fre-
quently accompanies obesity 10 are other 
fields of considerable clinical interest in 
attacking the epidemic of obesity-related 
renal disease through modifi cations in diet. 
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 Figure 1  |  Reduction in proteinuria in a group of obese patients subjected to a low-calorie 
diet. One month after the onset of caloric restriction, proteinuria had decreased 26.4 ± 30 % of 
baseline values (from 2.8 ± 1.4 to 2 ± 1.5  g per 24  h) in spite of a modest weight loss (2.8 ± 2.1 % of the 
baseline values). (Adapted with permission from Morales  et al . 8 ). 
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 In this issue of  Kidney International , 
Polzin  et al. 1 suggest a connection between 
corin, atrial natriuretic peptide (ANP), 
  -epithelial sodium channel (  -ENaC), 
and phosphodiesterase 5 (PDE5) in the 
Na   +   and volume retention in nephrotic 
syndrome and leave one with more 
 questions than answers. The authors 
explore the role of corin in the kidney in 
animal models of kidney disease. Th ey 
identifi ed corin as a protein of interest in 
this pathology through the use of a micro-
array analysis of kidneys from rats with 
nephrotic syndrome. Of all the proteins 
that changed, why did these scientists look 
at corin as particularly interesting? 
 Corin is a recently discovered 2 serine /
 threonine protease that has mostly been 
studied in connection with the heart, as 
ANP is a substrate for corin. Corin cleaves 
the pro form of ANP at serine 124 to yield 
the active ANP and, hence, plays an 
important role in the response of the heart 
to high blood pressure or high blood vol-
ume. Although synthesized in the heart, 
ANP is released into the circulation in 
response to high blood pressure and 
moves to target organs such as the kidney, 
where it binds to its receptor, natriuretic 
peptide receptor A (NPR-A), and increases 
cyclic guanosine monophosphate (cGMP) 
production. ANP is also produced in the 
kidney, suggesting that corin in the kidney 
may specifi cally address renal responses 
through ANP. 3 Increased cGMP promotes 
a variety of eff ects, including stimulation 
of cGMP-dependent protein kinases with 
a resulting decrease in renin release, sup-
porting aff erent vasodilation and eff erent 
vasoconstriction, and blocking sodium 
and water transport in the proximal tubule 
and ENaC in the collecting duct. It will 
also stimulate cGMP-dependent phos-
phodiesterases, initiating an exquisitely 
sensitive feedback control of the eff ects of 
cGMP release. Th e consequences of ANP 
release, therefore, are natriuresis, diuresis, 
and vasodilation resulting in a lowering of 
blood volume and salt retention. 4 
 Although corin is known to cleave ANP, 
its role in the kidney remains largely unex-
plored. Polzin  et al. 1 explore the possibil-
ity that corin may do more than activate 
ANP, and they present compelling data 
that suggest a connection between the 
proteolytic action of corin and the 
response of ENaC in nephrotic syndrome. 
Th e authors used two rat models in their 
studies: the puromycin aminonucleoside-
induced nephrotic syndrome and anti-
Th y1-induced glomerulonephritis. Th ey 
paired these animal models with studies 
in transfected mpkCCD cells in culture. 
Th e background data that support a role 
for corin are strong. Th e authors present 
microarray data showing that corin 
mRNA in the inner medulla of the neph-
rotic kidney is reduced as compared with 
control levels. While message was not 
reduced in the cortex, corin protein levels 
were reduced, and this was refl ected in a 
decreased level of active ANP and an 
increased level of pro-ANP. In an immu-
nohistochemical analysis, they found 
corin in the proximal tubule in subapical 
vesicles, in the thick ascending limb in 
 Corin: an ANP protease that may 
regulate sodium reabsorption 
in nephrotic syndrome 
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 The serine / threonine protease corin, which proteolytically activates atrial 
natriuretic peptide (ANP), is reduced in the kidneys of animals with 
nephrotic syndrome and glomerular nephritis. Polzin  et al. provide 
evidence for a linkage between the decreased corin and   -epithelial 
sodium channel, phosphodiesterase 5, and cGMP-dependent protein 
kinase II in the nephrotic kidney. They propose that decreases in cGMP 
resulting from the reduced corin may be responsible for the Na   +   retention 
and volume expansion that are hallmarks of these kidney diseases. 
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